Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects
Top Cited Papers
- 1 January 2008
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 47 (1) , 47-59
- https://doi.org/10.2165/00003088-200847010-00005
Abstract
Objectives To investigate the pharmacokinetic and pharmacodynamic profile of dabigatran in healthy elderly subjects; to assess the intra- and interindividual variability of dabigatran pharmacokinetics...Keywords
This publication has 23 references indexed in Scilit:
- The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBritish Journal of Clinical Pharmacology, 2007
- Bridging the gap: ageing, pharmacokinetics and pharmacodynamicsJournal of Pharmacy and Pharmacology, 2005
- Understanding the dynamics of thrombin in cardiovascular disease: Pathobiology and biochemistry for the clinicianAmerican Heart Journal, 2005
- Oral Direct Thrombin InhibitionDrugs, 2004
- Serine proteases as targets for antithrombotic therapyDrugs of the Future, 2003
- Monitoring of Anticoagulant Effects of Direct Thrombin InhibitorsSeminars in Thrombosis and Hemostasis, 2002
- Clinical Monitoring of Hirudin and Direct Thrombin InhibitorsSeminars in Thrombosis and Hemostasis, 2001
- Age-Dependent Changes of the Kidneys: Pharmacological ImplicationsGerontology, 1999
- THE AGING GUT: Nutritional IssuesGastroenterology Clinics of North America, 1998
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987